BRPI0823096A2 - Composição de opioide farmacêutica de liberação controlada, dependente do ph, com resistência contra a influência do etanol - Google Patents

Composição de opioide farmacêutica de liberação controlada, dependente do ph, com resistência contra a influência do etanol

Info

Publication number
BRPI0823096A2
BRPI0823096A2 BRPI0823096-0A BRPI0823096A BRPI0823096A2 BR PI0823096 A2 BRPI0823096 A2 BR PI0823096A2 BR PI0823096 A BRPI0823096 A BR PI0823096A BR PI0823096 A2 BRPI0823096 A2 BR PI0823096A2
Authority
BR
Brazil
Prior art keywords
controlled release
resistance against
release pharmaceutical
dependent controlled
against ethanol
Prior art date
Application number
BRPI0823096-0A
Other languages
English (en)
Inventor
Hans Bar
Thomas Furst
Gerhard Renner
Michael Gottschalk
Original Assignee
Evonik Roehm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm Gmbh filed Critical Evonik Roehm Gmbh
Publication of BRPI0823096A2 publication Critical patent/BRPI0823096A2/pt
Publication of BRPI0823096B1 publication Critical patent/BRPI0823096B1/pt
Publication of BRPI0823096B8 publication Critical patent/BRPI0823096B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0823096A 2008-09-24 2008-09-24 composição farmacêutica de opióide de liberação controlada, dependente do ph, com resistência contra a influência do etanol, processo para sua preparação, e seu uso BRPI0823096B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2008/062761 WO2010034342A1 (en) 2008-09-24 2008-09-24 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol

Publications (3)

Publication Number Publication Date
BRPI0823096A2 true BRPI0823096A2 (pt) 2015-06-16
BRPI0823096B1 BRPI0823096B1 (pt) 2019-07-02
BRPI0823096B8 BRPI0823096B8 (pt) 2022-07-05

Family

ID=40691361

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0823096A BRPI0823096B8 (pt) 2008-09-24 2008-09-24 composição farmacêutica de opióide de liberação controlada, dependente do ph, com resistência contra a influência do etanol, processo para sua preparação, e seu uso

Country Status (13)

Country Link
US (1) US9757343B2 (pt)
EP (1) EP2341899B1 (pt)
JP (1) JP5453433B2 (pt)
KR (1) KR101528957B1 (pt)
CN (1) CN102164588B (pt)
BR (1) BRPI0823096B8 (pt)
CA (1) CA2738078C (pt)
ES (1) ES2532877T3 (pt)
IL (1) IL211306A (pt)
MX (1) MX2011003047A (pt)
PL (1) PL2341899T3 (pt)
SI (1) SI2341899T1 (pt)
WO (1) WO2010034342A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3095447T3 (da) 2006-02-03 2022-01-31 Opko Renal Llc Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
DK2679228T3 (en) 2006-06-21 2018-06-06 Opko Ireland Global Holdings Ltd Therapy with a vitamin D refill and a vitamin D hormone replacement
PL3542792T3 (pl) 2007-04-25 2023-11-20 Eirgen Pharma Ltd. 25-hydroksywitamina d o kontrolowanym uwalnianiu
EP3225243B1 (en) 2007-04-25 2025-09-03 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
ES2403107T3 (es) 2007-04-25 2013-05-14 Cytochroma Inc. Método de tratamiento de insuficiencia y deficiencia de vitamina D
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
CA2755808C (en) 2009-03-18 2016-01-19 Evonik Operations Gmbh Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising neutral vinyl polymers and excipients
SMT202000167T1 (it) 2010-03-29 2020-05-08 Opko Ireland Global Holdings Ltd Metodi e composizioni per la riduzione dei livelli paratiroidei
NZ603170A (en) 2010-05-10 2015-04-24 Euro Celtique Sa Combination of active loaded granules with additional actives
NZ700732A (en) 2010-05-10 2015-08-28 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
AU2011252040C1 (en) 2010-05-10 2015-04-02 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
PL2720681T3 (pl) 2011-06-17 2017-05-31 Evonik Röhm Gmbh Kompozycja powlekająca odpowiednia do farmaceutycznych lub nutraceutycznych postaci dawkowania
PL2720682T3 (pl) 2011-06-17 2017-05-31 Evonik Röhm Gmbh Kompozycja powlekająca odpowiednia do farmaceutycznych lub nutraceutycznych postaci dawkowania
HUE030548T2 (en) * 2011-06-17 2017-05-29 Evonik Roehm Gmbh A stomach-resistant medical or nutritional preparation that is resistant to ethanol
US9155734B2 (en) * 2012-03-07 2015-10-13 Mallinckrodt Llc Stability of hydromorphone hydrochloride solutions
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
CN103271940B (zh) * 2013-05-03 2014-03-12 湖北新济药业有限公司 复方金属离子补充剂及其制备方法
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
CN106061471A (zh) * 2014-02-17 2016-10-26 赢创罗姆有限公司 具有持续释放特性并针对乙醇的影响具有抗性的药物或营养组合物
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
US11229600B2 (en) * 2014-09-24 2022-01-25 Vital Beverages Global Inc. Compositions and methods for selective GI tract delivery
SG11201808227YA (en) 2016-03-28 2018-10-30 Opko Ireland Global Holdings Limited Methods of vitamin d treatment
KR101942922B1 (ko) 2017-01-20 2019-01-30 한국해양대학교 산학협력단 실리콘 나노입자를 포함하는 리튬이차전지용 음극활물질 및 그 제조방법
KR20200057019A (ko) 2017-09-14 2020-05-25 에보닉 오퍼레이션스 게엠베하 서방성 및 에탄올의 영향에 대한 내성을 갖는 중합체 및 투여 형태
CA3093077A1 (en) 2018-03-09 2019-09-12 Evonik Operations Gmbh Polymer mixture with resistance against the influence of ethanol
CN114949220B (zh) * 2022-01-30 2023-09-22 浙江大学 一种靶向损伤节段背根神经节的pH响应镇痛药及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20030118641A1 (en) * 2000-07-27 2003-06-26 Roxane Laboratories, Inc. Abuse-resistant sustained-release opioid formulation
ES2230154T3 (es) 1999-08-27 2005-05-01 Southern Research Institute Composiciones inyectables de buprenorfina y su utilizacion para reduccion del consumo de heroina y alcohol.
WO2003009831A1 (fr) 2001-07-27 2003-02-06 Yamanouchi Pharmaceutical Co., Ltd. Compositions contenant des grains fins a liberation prolongee pour comprimes a desagregation rapide dans la cavite buccale et procede de production associe
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
EP2289491A1 (en) 2005-01-28 2011-03-02 Euro-Celtique S.A. Alcohol resistant dosage forms
DE102005024614A1 (de) * 2005-05-25 2006-11-30 Röhm Gmbh Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
RU2433817C2 (ru) 2006-01-21 2011-11-20 Эбботт Гмбх Унд Ко.Кг Лекарственная форма и способ для доставки вызывающих зависимость лекарственных веществ
DE102006051020A1 (de) * 2006-10-26 2008-04-30 Evonik Röhm Gmbh Verwendung von (Meth)acrylat-Copolymeren in Retard-Arzneiformen zur Verringerung des Einflusses von Ethanol auf die Wirkstofffreisetzung
KR101454056B1 (ko) * 2007-09-21 2014-10-27 에보니크 룀 게엠베하 에탄올의 영향에 대하여 내성을 가지는 비-오피오이드용 ｐｈ-의존성 조절 방출 제약 조성물
PL2187876T3 (pl) * 2007-09-21 2013-01-31 Evonik Roehm Gmbh Farmaceutyczna kompozycja opioidowa o zależnym od pH kontrolowanym uwalnianiu z odpornością przed wpływem etanolu

Also Published As

Publication number Publication date
WO2010034342A1 (en) 2010-04-01
US9757343B2 (en) 2017-09-12
JP2012503608A (ja) 2012-02-09
CA2738078C (en) 2015-12-29
CA2738078A1 (en) 2010-04-01
IL211306A (en) 2015-01-29
CN102164588A (zh) 2011-08-24
BRPI0823096B1 (pt) 2019-07-02
PL2341899T3 (pl) 2015-05-29
KR101528957B1 (ko) 2015-06-17
JP5453433B2 (ja) 2014-03-26
EP2341899A1 (en) 2011-07-13
ES2532877T3 (es) 2015-04-01
SI2341899T1 (sl) 2015-04-30
CN102164588B (zh) 2015-07-08
BRPI0823096B8 (pt) 2022-07-05
KR20110058835A (ko) 2011-06-01
IL211306A0 (en) 2011-04-28
US20110217383A1 (en) 2011-09-08
MX2011003047A (es) 2011-04-14
EP2341899B1 (en) 2014-12-17

Similar Documents

Publication Publication Date Title
BRPI0823096A2 (pt) Composição de opioide farmacêutica de liberação controlada, dependente do ph, com resistência contra a influência do etanol
BRPI0823128A2 (pt) Composição farmacêutica de liberação controlada dependente do ph para não opioides com resistência contra a influência de etanol.
SI2187876T1 (sl) Od pH odvisen opioidni farmacevtski sestavek z nadzorovanim sproščanjem z odpornostjo na vpliv etanola
CY2017017I2 (el) Φαρμακευτικη συνθεση που περιλαμβανει βενζολικο παραγωγο υποκατεστημενο με γλυκοπυρανοζυλιο
IL203870A (en) PH-dependent drug release for non-opioid and alcohol-resistant substances
EP2268361B8 (en) Percutaneous probe
EP2265662A4 (en) BIOLOGICAL SOFTENER FOR BIOPOLYMERS
MX301000B (es) Produccion de etanol en microorganismos.
ZA201103887B (en) Isoxazole derivatives for use as fungicides
ZA200901268B (en) Substituted imidazolone derivatives, preparation and uses
PL2191828T3 (pl) Przeciwgrzybicza kompozycja farmaceutyczna
EP2344471A4 (en) 7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE
BRPI0917446A2 (pt) derivados de acilaminobenzamida.
PT2193795E (pt) Composição farmacêutica aquosa contendo latanoprost
BRPI0906714A2 (pt) Derivados de oxazepinopirimidona heteroarilamida substituídos.
BRPI0921483A2 (pt) fermentacao melhorada de etanol usando biodigestado
BRPI0923875A2 (pt) Derivados de 2-piridin-2-il-pirazol-3 (2h)-ona, o respectivo preparo e a respectiva aplicação terapêutica.
BRPI0806938A2 (pt) Composição farmacêutica contedo um derivado de camptotecina
DK2164898T3 (da) EVOH-blanding til forbedret oxygenbestandighed
IT1397968B1 (it) Composizione pesticida acquosa.
BRPI0912331A2 (pt) distribuidor.
BRPI0916702A2 (pt) composto, uso de um composto, e, composição farmacêutica.
BRPI0907156A2 (pt) Produção de etanol aumentada por células bacterianas
BRPI0907749A2 (pt) Derivados de 3,8-diaminotetrahidroquinolina
IL201912A0 (en) Aqueous pharmaceutical composition

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REFERENTE RPI NO 2490 DE 25-09-2018

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/07/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/09/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25D Requested change of name of applicant approved

Owner name: ROEHM GMBH (DE)

B25G Requested change of headquarter approved

Owner name: ROEHM GMBH (DE)

B25A Requested transfer of rights approved

Owner name: EVONIK DEGUSSA GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: EVONIK OPERATIONS GMBH (DE)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2741 DE 18-07-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.